Liver fibrosis is independent of methotrexate use in patients with moderate-to-severe psoriasis

被引：0
|
作者：
Babakinejad, Parastoo [1 ]
Lapsley, Rebecca [1 ]
Foster, Lara [2 ]
McPherson, Stuart [1 ]
Pearce, Mark [2 ]
Reynolds, Nick [1 ]
Slack, Emma [2 ]
Weatherhead, Sophie [1 ]
Hampton, Philip [1 ]
机构：
[1] Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
D O I：
10.1093/bjd/ljad113.096
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P68
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Dauden, E.
    Prieto-Perez, R.
    Llamas-Velasco, M.
    Cabaleiro, T.
    Abad-Santos, F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S188 - S188
  • [22] Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis
    Papp, Kim A.
    Lebwohl, Mark G.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (03) : 247 - 250
  • [23] Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis
    Revicki, Dennis A.
    Jin, Ying
    Wilson, Hilary D.
    Chau, Dina
    Viswanathan, Hema N.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (01) : 8 - 14
  • [24] Methotrexate for moderate-to-severe atopic eczema
    Weatherhead, S.
    Wahie, S.
    Reynods, N. J.
    Meggitt, S. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 : 44 - 44
  • [25] Cost per responder for methotrexate versus other therapies in patients with moderate-to-severe plaque psoriasis in Italy
    Pompilio, Giuseppe
    Integlia, Davide
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2022, 9 : 138 - 145
  • [26] Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)
    Paul, C.
    Puig, L.
    Kragballe, K.
    Luger, T.
    Lambert, J.
    Chimenti, S.
    Girolomoni, G.
    Nicolas, J. -F.
    Rizova, E.
    Lavie, F.
    Mistry, S.
    Bergmans, P.
    Barker, J.
    Reich, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (02) : 425 - 434
  • [27] Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis
    Leman, J.
    Burden, A. D.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 : 12 - 20
  • [28] Use of extended courses of alefacept in the treatment of moderate-to-severe psoriasis
    Gupta, Aditya
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB192 - AB192
  • [29] Tofacitinib for the treatment of moderate-to-severe psoriasis
    Chiricozzi, Andrea
    Faleri, Sara
    Saraceno, Rosita
    Bianchi, Luca
    Buonomo, Oreste
    Chimenti, Sergio
    Chimenti, Maria Sole
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (04) : 443 - 455
  • [30] Managing Moderate-to-Severe Psoriasis in the Elderly
    Nicola Balato
    Cataldo Patruno
    Maddalena Napolitano
    Angela Patrì
    Fabio Ayala
    Raffaele Scarpa
    Drugs & Aging, 2014, 31 : 233 - 238
12345